Source:http://linkedlifedata.com/resource/pubmed/id/10642284
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1 Pt 1
|
pubmed:dateCreated |
2000-2-9
|
pubmed:abstractText |
It is known that hyperaldosteronism has been associated with magnesium deficiency, yet there are no data on the intracellular concentration of ionized magnesium ([Mg(2+)(i)]) in subjects with primary aldosteronism (PA). We measured intralymphocyte free magnesium ([Mg(2+)(i)]) and intralymphocyte free calcium ([Ca(2+)(i)]) in 16 patients with PA and 26 normotensive control subjects (NCs). [Mg(2+)(i)] and [Ca(2+)(i)] were also measured in blood lymphocytes incubated in vitro with aldosterone, according to a fluorimetric method. In subjects with PA, [Mg(2+)(i)] was significantly lower than that in NCs (mean+/-SD; PA 203+/-56 micromol/L, NCs 291+/-43 micromol/L, 95% confidence interval 57 to 119, P=0.001). In the patients, [Ca(2+)(i)] did not prove to be statistically different from that of NCs (mean+/-SD; PA 47.2+/-10.6 nmol/L, NCs 53.2+/-11 nmol/L). The lymphocytes exposed to the action of aldosterone showed a significant reduction in [Mg(2+)(i)] (n=15, NCs 271+/-28 micromol/L, aldosterone treatment 188+/-39 micromol/L, P=0.001, 95% confidence interval 57 to 108). The dose-effect curve of aldosterone on [Mg(2+)(i)] showed an EC(50) value of approximately 0.5 to 1 nmol/L aldosterone. The reduction in [Mg(2+)(i)] mediated by aldosterone is antagonized by the receptor inhibitor of aldosterone; it is inhibited by inhibitors of protein synthesis and is not measurable when the lymphocytes are incubated in an Na(+)-free medium. The data are consistent with the hypothesis that aldosterone affects the cellular homeostasis of magnesium, probably through modification of the activity of the Na(+)-Mg(2+) antiporter.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Aldosterone,
http://linkedlifedata.com/resource/pubmed/chemical/Aldosterone Antagonists,
http://linkedlifedata.com/resource/pubmed/chemical/Antiporters,
http://linkedlifedata.com/resource/pubmed/chemical/Calcium,
http://linkedlifedata.com/resource/pubmed/chemical/Canrenoate Potassium,
http://linkedlifedata.com/resource/pubmed/chemical/Magnesium,
http://linkedlifedata.com/resource/pubmed/chemical/sodium-magnesium antiporter
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0194-911X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
35
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
113-7
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:10642284-Adult,
pubmed-meshheading:10642284-Aldosterone,
pubmed-meshheading:10642284-Aldosterone Antagonists,
pubmed-meshheading:10642284-Antiporters,
pubmed-meshheading:10642284-Calcium,
pubmed-meshheading:10642284-Canrenoate Potassium,
pubmed-meshheading:10642284-Case-Control Studies,
pubmed-meshheading:10642284-Female,
pubmed-meshheading:10642284-Homeostasis,
pubmed-meshheading:10642284-Humans,
pubmed-meshheading:10642284-Hyperaldosteronism,
pubmed-meshheading:10642284-Lymphocytes,
pubmed-meshheading:10642284-Magnesium,
pubmed-meshheading:10642284-Magnesium Deficiency,
pubmed-meshheading:10642284-Male,
pubmed-meshheading:10642284-Middle Aged
|
pubmed:year |
2000
|
pubmed:articleTitle |
Intralymphocyte free magnesium in patients with primary aldosteronism: aldosterone and lymphocyte magnesium homeostasis.
|
pubmed:affiliation |
Departments of Biomedic and Surgical Sciences, University of Verona, Policlinico Borgo Roma, Verona, Italy. delvap@borgoroma.univr.it
|
pubmed:publicationType |
Journal Article,
In Vitro,
Research Support, Non-U.S. Gov't
|